Editorial: Psychoactive natural products: Potential in the treatment of brain diseases and strategies to improve delivery

Editorial: Psychoactive natural products: Potential in the treatment of brain diseases and strategies to improve delivery

Bibliographic Details
Main Authors:	Célia Cabral, Claudia Carbone, Pamela Maher, Miguel Castelo-Branco
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Pharmacology
Subjects:	psychoactive natural products brain diseases new molecules new therapies drug delivery
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1032496/full

Similar Items

In vitro neuro- and hepatotoxic profile of new psychoactive phenethylamines
by: Eva Gil-Martins, et al.
Published: (2022-04-01)

New psychoactive substances: An emerging epidemic
by: Kranti Kadam
Published: (2019-01-01)

Generic bans of new psychoactive substances
by: Risimović Radosav S.
Published: (2018-01-01)

New psychoactive substances abuse and its clinical consequences - the case report
by: Andrzej Kościuk, et al.
Published: (2019-08-01)

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
by: Hsin-Tzu Yeh, et al.
Published: (2022-07-01)

Update on Critical Issues and Current Challenges with “Newer Psychoactive Substances: An Narrative Review”
by: Raka Jain, et al.
Published: (2022-01-01)

Editorial: Old and new psychoactive substances: Pharmacology and potential applications
by: Felix P. Mayer, et al.
Published: (2023-01-01)

New psychoactive substances and the risks of consumption in children and adolescents
by: Viorela Nitescu
Published: (2019-12-01)

Analytically confirmed presence of psychoactive substances, especially new psychoactive substances in a group of patients hospitalized with mental and behavioural disorders due to the use of psychoactive substances diagnosis
by: Piotr Engelgardt, et al.
Published: (2022-05-01)

New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
by: Alfredo Fabrizio Lo Faro, et al.
Published: (2023-02-01)

Pharmacokinetics and metabolomics of the new psychoactive substance 4-chloroethylcathinone
by: Yong Wang, et al.
Published: (2023-09-01)

Prevalence of new psychoactive substances addiction: a hospital-based cross-sectional study
by: Mariya Prilutskaya, et al.
Published: (2020-03-01)

Voltammetric Analysis of New Psychoactive Substances
by: Ketan Patil, et al.
Published: (2021-12-01)

New psychoactive substances: Issues and challenges
by: Vaibhav Patil, et al.
Published: (2016-01-01)

New Psychoactive Substances: A Potential Threat to Developing Countries
by: Mehedi Hasan, et al.
Published: (2023-04-01)

Awareness of users and motivational factors for using new psychoactive substances in Belgium
by: Sarah Simonis, et al.
Published: (2020-07-01)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
by: Maria Alías-Ferri, et al.
Published: (2022-04-01)

A Photoluminescent Colorimetric Probe of Bovine Serum Albumin-Stabilized Gold Nanoclusters for New Psychoactive Substances: Cathinone Drugs in Seized Street Samples
by: Yao-Te Yen, et al.
Published: (2019-08-01)

Uncovering the Metabolic Footprint of New Psychoactive Substances by Metabolomics: A Systematic Review
by: Ana Sofia Almeida, et al.
Published: (2025-01-01)

Taking the cat-and-mouse game to the next level: different perspectives on the introduction of the German New Psychoactive Substances Act
by: Regina Kühnl, et al.
Published: (2022-11-01)

AddictedChem: A Data-Driven Integrated Platform for New Psychoactive Substance Identification
by: Mengying Han, et al.
Published: (2022-06-01)

Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil
by: Sascha K. Manier, et al.
Published: (2024-06-01)

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
by: Stefania Chiappini, et al.
Published: (2021-06-01)

Similarities and differences in changing NPS market brought by new regulatory approaches in selected Eastern and Central European states with mostly focus on Poland and Latvia
by: Artur Malczewski, et al.
Published: (2019-06-01)

Editorial: Pharmacology of new psychoactive substances
by: K. Lutfy, et al.
Published: (2023-05-01)

Editorial: Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies
by: Mariana Magalhães, et al.
Published: (2024-06-01)

Unusual/unconventional psychoactive substances of abuse
by: Anil Kakunje, et al.
Published: (2018-11-01)

The influence of tightening regulations on patients with new psychoactive substance‐related disorders in Japan
by: Yuko Tanibuchi, et al.
Published: (2018-12-01)

Simultaneous identification of abused drugs, benzodiazepines, and new psychoactive substances in urine by liquid chromatography tandem mass spectrometry
by: Hei-Hwa Lee, et al.
Published: (2016-03-01)

Applications of Sample Preparation Techniques in the Analysis of New Psychoactive Substances
by: Lorna A. Nisbet, et al.
Published: (2024-08-01)

New Psychoactive Substances: Health and Legal Challenges
by: Inês C. Santos, et al.
Published: (2024-06-01)

Exploring the topic structure and abuse trends of new psychoactive Substance since the 21st century from a bibliometric perspective
by: Xiaolong Hou, et al.
Published: (2024-04-01)

Scientific, Methodological and Organizational Approaches to Conducting Pre-clinical and Expert studies of Substances with Psychoactive Properties
by: T. L. Malkova, et al.
Published: (2023-12-01)

The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
by: Elle Wadsworth, et al.
Published: (2018-03-01)

Determination of Psychoactive Mitragynine Drug in Suspected Kratom Species Collected from Various Geographical Areas in the Philippines: A Pilot Study on Existing Local Plant-based New Psychoactive Su
by: Atty. Severino P. Uy, et al.
Published: (2019-12-01)

Determination of Eight New Psychoactive Substances Derived from Cathinones in Tea by Gas Chromatography-Mass Spectrometry
by: TANG Qingqiang, WANG Jun, ZHANG Huiqin, WANG Qiaoxia, CAO Xiaogang, WU Chundeng, YANG Fang
Published: (2024-08-01)

Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT)
by: Carla Soares, et al.
Published: (2024-10-01)

Pathophysiological mechanisms and clinical consequences of exposure to new psychoactive substances (“salts”) on a newborn
by: Elena V. Loshkova, et al.
Published: (2023-12-01)

Research Progress on Metabolite Identification of Synthetic Cannabinoid New Psychoactive Substances
by: LI Le, ZHAO Jun-bo, YAN Hui, et al.
Published: (2021-08-01)

Fatal cases involving new psychoactive substances and trends in analytical techniques
by: Ettore Ferrari Júnior, et al.
Published: (2022-10-01)